Cystatin C Assay Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2030, Segmented By Product ; By Sample Type ; By Method ; By Application ; By End-User ; By Region

Description

Global Cystatin C Assay Market Size Expands at CAGR of 6.45% During 2024-2030 to Surpass USD 421 Million by 2030

Global Cystatin C Assay Market is flourishing because of an increasing focus on the diagnosis, treatment, and management of rising prevalence of renal diseases and growing awareness about kidney health.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Cystatin C Assay Market size at USD 271.98 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Cystatin C Assay Market size to expand at a CAGR of 6.45% reaching a value of USD 421.22 million by 2030. Favorable government policies and the growing awareness and use of cystatin C testing in the healthcare sector are major driving factors for the Global Cystatin C Assay Market. Furthermore, it is projected that the Global Cystatin C Assay Market will witness significant expansion due to the growing incidence of renal disorders and the focus on early disease identification.

Opportunity: Extensive Research Activities and Launch of New Products

The Global Cystatin C Assay Market is expanding as a result of pharmaceutical, biotechnology, and research institutions making substantial investments in research and development due to the increasing demand for the diagnosis and treatment of rising frequency of kidney-related disorders. For example, recent research published in the New England Journal of Medicine demonstrates an alternate method of removing a person's race from the kidney function evaluation process, which frequently resulted in racial health disparities, by utilizing blood cystatin C testing rather than blood creatinine testing.

Impact of Escalating Geopolitical Tensions on Global Cystatin C Assay Market

The escalating geopolitical tensions has hindered the growth of the Global Cystatin C Assay Market. For instance, patients living with kidney issues in war-torn areas of Ukraine and Palestine have had their access to healthcare services cut, which directly influenced the number of cystatin C tests performed in these regions. Ukraine is a leading healthcare and pharmaceutical hub in the world. However, Russia's invasion on Ukraine led to shortage of medical resources in the country as well as disruption in the medical research and development.

Global Cystatin C Assay Market

Segmental Coverage

Global Cystatin C Assay Market - By Method

Based on method, the Global Cystatin C Assay Market is segmented into enzyme-linked immunosorbent assay (ELISA), particle-enhanced turbidimetric immunoassay (PETIA), particle-enhanced nephelometric immunoassays (PENIA), chemiluminescent immunoassay (CLIA), immunofluorescence assay, and others. The ELISA segment accounts for the highest market share. The ELISA method is simple and offers high sensitivity and specificity in disease diagnosis. The main advantage of ELISA testing is that the temporal window for infection detection is substantially larger, making it easier to determine whether an infection is occurring or has occurred.

Global Cystatin C Assay Market - By Region

The in-depth research report on the Global Cystatin C Assay Market covers a number of country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa. North America dominates the Global Cystatin C Assay Market owing to rising healthcare expenditure, the increasing prevalence of kidney-related diseases, and the rising geriatric population. Furthermore, increasing research activities surrounding cystatin C assay testing in biotechnology and pharmaceutical companies are anticipated to present lucrative growth opportunities to the market during the forecast period.

Competitive Landscape

Major players operating in the Global Cystatin C Assay Market include Roche Diagnostics, Abbott Laboratories, Siemens Healthineers, Randox Laboratories, DiaSys Diagnostic Systems, Sysmex Corporation, Fujifilm Wako, Thermo Fisher Scientific, BioMerieux, and Abcam.

These businesses use a range of tactics, such as partnerships, joint ventures, license agreements, mergers and acquisitions, and the introduction of new products, to increase their market share.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Cystatin C Assay Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Cystatin C Assay Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Product Code: BWC24112

1. Research Framework

1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation

2. Executive Summary

3. Global Cystatin C Assay Market Insights

3.1. Industry Value Chain Analysis
3.2. DROC Analysis
- 3.2.1. Growth Drivers
  - 3.2.1.1. Rising Prevalence of Kidney Diseases
  - 3.2.1.2. Growing Awareness of Kidney Health
  - 3.2.1.3. Growing Aging Population
- 3.2.2. Restraints
  - 3.2.2.1. Lack of Awareness Among Healthcare Professionals
  - 3.2.2.2. Reimbursement Challenges
- 3.2.3. Opportunities
  - 3.2.3.1. Development of Combination Tests
  - 3.2.3.2. Growing Acceptance in Emerging Markets
- 3.2.4. Challenges
  - 3.2.4.1. Competition from Alternative Methods
  - 3.2.4.2. Data Standardization
3.3. Technological Advancements/Recent Developments
3.4. Regulatory Framework
3.5. Porter's Five Forces Analysis
- 3.5.1. Bargaining Power of Suppliers
- 3.5.2. Bargaining Power of Buyers
- 3.5.3. Threat of New Entrants
- 3.5.4. Threat of Substitutes
- 3.5.5. Intensity of Rivalry

4. Global Cystatin C Assay Market Overview

4.1. Market Size & Forecast, 2019-2030
- 4.1.1. By Value (USD Million)
4.2. Market Share and Forecast
- 4.2.1. By Product
  - 4.2.1.1. Kits
  - 4.2.1.2. Reagents
  - 4.2.1.3. Analyzers
- 4.2.2. By Sample Type
  - 4.2.2.1. Blood
  - 4.2.2.2. Urine
- 4.2.3. By Method
  - 4.2.3.1. Enzyme-Linked Immunosorbent Assay (ELISA)
  - 4.2.3.2. Particle-Enhanced Turbidimetric Immunoassay (PETIA)
  - 4.2.3.3. Particle-Enhanced Nephelometric Immunoassay (PENIA)
  - 4.2.3.4. Chemiluminescent Immunoassay (CLIA)
  - 4.2.3.5. Immunofluorescence Assay
  - 4.2.3.6. Others
- 4.2.4. By Application
  - 4.2.4.1. Diagnostics
  - 4.2.4.2. Research
- 4.2.5. By End User
  - 4.2.5.1. Hospitals
  - 4.2.5.2. Clinical Laboratories
  - 4.2.5.3. Pharmaceutical And Biotechnology Companies
  - 4.2.5.4. Others
- 4.2.6. By Region
  - 4.2.6.1. North America
  - 4.2.6.2. Europe
  - 4.2.6.3. Asia Pacific (APAC)
  - 4.2.6.4. Latin America (LATAM)
  - 4.2.6.5. Middle East and Africa (MEA)

5. North America Cystatin C Assay Market

5.1. Market Size & Forecast, 2019-2030
- 5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
- 5.2.1. By Product
- 5.2.2. By Sample Type
- 5.2.3. By Method
- 5.2.4. By Application
- 5.2.5. By End User
- 5.2.6. By Country
  - 5.2.6.1. United States
  - 5.2.6.1.1. By Product
  - 5.2.6.1.2. By Sample Type
  - 5.2.6.1.3. By Method
  - 5.2.6.1.4. By Application
  - 5.2.6.1.5. By End User
  - 5.2.6.2. Canada
  - 5.2.6.2.1. By Product
  - 5.2.6.2.2. By Sample Type
  - 5.2.6.2.3. By Method
  - 5.2.6.2.4. By Application
  - 5.2.6.2.5. By End User

6. Europe Cystatin C Assay Market

6.1. Market Size & Forecast, 2019-2030
- 6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
- 6.2.1. By Product
- 6.2.2. By Sample Type
- 6.2.3. By Method
- 6.2.4. By Application
- 6.2.5. By End User
- 6.2.6. By Country
  - 6.2.6.1. Germany
  - 6.2.6.1.1. By Product
  - 6.2.6.1.2. By Sample Type
  - 6.2.6.1.3. By Method
  - 6.2.6.1.4. By Application
  - 6.2.6.1.5. By End User
  - 6.2.6.2. United Kingdom
  - 6.2.6.2.1. By Product
  - 6.2.6.2.2. By Sample Type
  - 6.2.6.2.3. By Method
  - 6.2.6.2.4. By Application
  - 6.2.6.2.5. By End User
  - 6.2.6.3. Italy
  - 6.2.6.3.1. By Product
  - 6.2.6.3.2. By Sample Type
  - 6.2.6.3.3. By Method
  - 6.2.6.3.4. By Application
  - 6.2.6.3.5. By End User
  - 6.2.6.4. France
  - 6.2.6.4.1. By Product
  - 6.2.6.4.2. By Sample Type
  - 6.2.6.4.3. By Method
  - 6.2.6.4.4. By Application
  - 6.2.6.4.5. By End User
  - 6.2.6.5. Spain
  - 6.2.6.5.1. By Product
  - 6.2.6.5.2. By Sample Type
  - 6.2.6.5.3. By Method
  - 6.2.6.5.4. By Application
  - 6.2.6.5.5. By End User
  - 6.2.6.6. Belgium
  - 6.2.6.6.1. By Product
  - 6.2.6.6.2. By Sample Type
  - 6.2.6.6.3. By Method
  - 6.2.6.6.4. By Application
  - 6.2.6.6.5. By End User
  - 6.2.6.7. Russia
  - 6.2.6.7.1. By Product
  - 6.2.6.7.2. By Sample Type
  - 6.2.6.7.3. By Method
  - 6.2.6.7.4. By Application
  - 6.2.6.7.5. By End User
  - 6.2.6.8. The Netherlands
  - 6.2.6.8.1. By Product
  - 6.2.6.8.2. By Sample Type
  - 6.2.6.8.3. By Method
  - 6.2.6.8.4. By Application
  - 6.2.6.8.5. By End User
  - 6.2.6.9. Rest of Europe
  - 6.2.6.9.1. By Product
  - 6.2.6.9.2. By Sample Type
  - 6.2.6.9.3. By Method
  - 6.2.6.9.4. By Application
  - 6.2.6.9.5. By End User

7. Asia Pacific Cystatin C Assay Market

7.1. Market Size & Forecast, 2019-2030
- 7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
- 7.2.1. By Product
- 7.2.2. By Sample Type
- 7.2.3. By Method
- 7.2.4. By Application
- 7.2.5. By End User
- 7.2.6. By Country
  - 7.2.6.1. China
  - 7.2.6.1.1. By Product
  - 7.2.6.1.2. By Sample Type
  - 7.2.6.1.3. By Method
  - 7.2.6.1.4. By Application
  - 7.2.6.1.5. By End User
  - 7.2.6.2. India
  - 7.2.6.2.1. By Product
  - 7.2.6.2.2. By Sample Type
  - 7.2.6.2.3. By Method
  - 7.2.6.2.4. By Application
  - 7.2.6.2.5. By End User
  - 7.2.6.3. Japan
  - 7.2.6.3.1. By Product
  - 7.2.6.3.2. By Sample Type
  - 7.2.6.3.3. By Method
  - 7.2.6.3.4. By Application
  - 7.2.6.3.5. By End User
  - 7.2.6.4. South Korea
  - 7.2.6.4.1. By Product
  - 7.2.6.4.2. By Sample Type
  - 7.2.6.4.3. By Method
  - 7.2.6.4.4. By Application
  - 7.2.6.4.5. By End User
  - 7.2.6.5. Australia & New Zealand
  - 7.2.6.5.1. By Product
  - 7.2.6.5.2. By Sample Type
  - 7.2.6.5.3. By Method
  - 7.2.6.5.4. By Application
  - 7.2.6.5.5. By End User
  - 7.2.6.6. Indonesia
  - 7.2.6.6.1. By Product
  - 7.2.6.6.2. By Sample Type
  - 7.2.6.6.3. By Method
  - 7.2.6.6.4. By Application
  - 7.2.6.6.5. By End User
  - 7.2.6.7. Malaysia
  - 7.2.6.7.1. By Product
  - 7.2.6.7.2. By Sample Type
  - 7.2.6.7.3. By Method
  - 7.2.6.7.4. By Application
  - 7.2.6.7.5. By End User
  - 7.2.6.8. Singapore
  - 7.2.6.8.1. By Product
  - 7.2.6.8.2. By Sample Type
  - 7.2.6.8.3. By Method
  - 7.2.6.8.4. By Application
  - 7.2.6.8.5. By End User
  - 7.2.6.9. Vietnam
  - 7.2.6.9.1. By Product
  - 7.2.6.9.2. By Sample Type
  - 7.2.6.9.3. By Method
  - 7.2.6.9.4. By Application
  - 7.2.6.9.5. By End User
  - 7.2.6.10. Rest of APAC
  - 7.2.6.10.1. By Product
  - 7.2.6.10.2. By Sample Type
  - 7.2.6.10.3. By Method
  - 7.2.6.10.4. By Application
  - 7.2.6.10.5. By End User

8. Latin America Cystatin C Assay Market

8.1. Market Size & Forecast, 2019-2030
- 8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
- 8.2.2. By Country
  - 8.2.2.1. Brazil
  - 8.2.2.1.1. By Product
  - 8.2.2.1.2. By Sample Type
  - 8.2.2.1.3. By Method
  - 8.2.2.1.4. By Application
  - 8.2.2.1.5. By End User
  - 8.2.2.2. Mexico
  - 8.2.2.2.1. By Product
  - 8.2.2.2.2. By Sample Type
  - 8.2.2.2.3. By Method
  - 8.2.2.2.4. By Application
  - 8.2.2.2.5. By End User
  - 8.2.2.3. Argentina
  - 8.2.2.3.1. By Product
  - 8.2.2.3.2. By Sample Type
  - 8.2.2.3.3. By Method
  - 8.2.2.3.4. By Application
  - 8.2.2.3.5. By End User
  - 8.2.2.4. Peru
  - 8.2.2.4.1. By Product
  - 8.2.2.4.2. By Sample Type
  - 8.2.2.4.3. By Method
  - 8.2.2.4.4. By Application
  - 8.2.2.4.5. By End User
  - 8.2.2.5. Rest of LATAM
  - 8.2.2.5.1. By Product
  - 8.2.2.5.2. By Sample Type
  - 8.2.2.5.3. By Method
  - 8.2.2.5.4. By Application
  - 8.2.2.5.5. By End User

9. Middle East & Africa Cystatin C Assay Market

9.1. Market Size & Forecast, 2019-2030
- 9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
- 9.2.1. By Product
- 9.2.2. By Sample Type
- 9.2.3. By Method
- 9.2.4. By Application
- 9.2.5. By End User
- 9.2.6. By Country
  - 9.2.6.1. Saudi Arabia
  - 9.2.6.1.1. By Product
  - 9.2.6.1.2. By Sample Type
  - 9.2.6.1.3. By Method
  - 9.2.6.1.4. By Application
  - 9.2.6.1.5. By End User
  - 9.2.6.2. UAE
  - 9.2.6.2.1. By Product
  - 9.2.6.2.2. By Sample Type
  - 9.2.6.2.3. By Method
  - 9.2.6.2.4. By Application
  - 9.2.6.2.5. By End User
  - 9.2.6.3. Qatar
  - 9.2.6.3.1. By Product
  - 9.2.6.3.2. By Sample Type
  - 9.2.6.3.3. By Method
  - 9.2.6.3.4. By Application
  - 9.2.6.3.5. By End User
  - 9.2.6.4. Kuwait
  - 9.2.6.4.1. By Product
  - 9.2.6.4.2. By Sample Type
  - 9.2.6.4.3. By Method
  - 9.2.6.4.4. By Application
  - 9.2.6.4.5. By End User
  - 9.2.6.5. South Africa
  - 9.2.6.5.1. By Product
  - 9.2.6.5.2. By Sample Type
  - 9.2.6.5.3. By Method
  - 9.2.6.5.4. By Application
  - 9.2.6.5.5. By End User
  - 9.2.6.6. Nigeria
  - 9.2.6.6.1. By Product
  - 9.2.6.6.2. By Sample Type
  - 9.2.6.6.3. By Method
  - 9.2.6.6.4. By Application
  - 9.2.6.6.5. By End User
  - 9.2.6.7. Algeria
  - 9.2.6.7.1. By Product
  - 9.2.6.7.2. By Sample Type
  - 9.2.6.7.3. By Method
  - 9.2.6.7.4. By Application
  - 9.2.6.7.5. By End User
  - 9.2.6.8. Rest of MEA
  - 9.2.6.8.1. By Product
  - 9.2.6.8.2. By Sample Type
  - 9.2.6.8.3. By Method
  - 9.2.6.8.4. By Application
  - 9.2.6.8.5. By End User

10. Competitive Landscape

10.1. List of Key Players and Their Offerings
10.2. Global Cystatin C Assay Market Share Analysis, 2023
10.3. Competitive Benchmarking, By Operating Parameters
10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Escalating Geopolitical Tensions on Global Cystatin C Assay Market

12. Impact of Covid-19 on Global Cystatin C Assay Market

13. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, and SWOT Analysis)

13.1. Roche Diagnostics
13.2. Abbott Laboratories
13.3. Siemens Healthineers
13.4. Randox Laboratories
13.5. DiaSys Diagnostic Systems
13.6. Sysmex Corporation
13.7. Fujifilm Wako
13.8. Thermo Fisher Scientific
13.9. bioMerieux
13.10. Abcam
13.11. Other Prominent Players

14. Key Strategic Recommendations

15. Research Methodology

15.1. Qualitative Research
- 15.1.1. Primary & Secondary Research
15.2. Quantitative Research
15.3. Market Breakdown & Data Triangulation
- 15.3.1. Secondary Research
- 15.3.2. Primary Research
15.4. Breakdown of Primary Research Respondents, By Region
15.5. Assumptions & Limitations